Email Updates

You are here

AVAC in the News

  • Experts in infectious disease and public health warn that the COVID-19 pandemic will be with us for a long time unless a vaccine becomes available soon, which is not likely. Estimates of how long it will take for an effective vaccine to come to market range from 12 to 18 months or longer. This situation has given rise to calls for human challenge studies. In these types of studies, researchers inject healthy volunteers with an experimental vaccine, after which the participants are infected with a strain of the disease in order to test the vaccine’s efficacy.

    May 15, 2020
    The Doctor’s Tablet Blog
  • An experimental vaccine seems to give monkeys extended protection from an HIV-like infection -- by "waking up" an arm of the immune system that vaccines normally do not. Experts cautioned that animal research often does not pan out in humans. The decades of work toward an HIV vaccine has been a clear example. But, researchers said, this vaccine works differently, targeting two "arms" of the immune system.

    May 11, 2020
    US News & World Report
  • During the COVID-19 crisis, a number of the ongoing worldwide HIV vaccine and immunotherapy efficacy trials are being paused or curtailed.

    April 22, 2020
  • While the COVID-19 pandemic is raging in the US, Africa faces the prospect of imminent catastrophe, where at least 300,000 Africans could die from the disease and 29 million people may be pushed into extreme poverty. Viruses do not respect borders, and we know that America will not be safe if COVID-19 is out of control on other continents.

    April 21, 2020
    The Hill
  • If one were to list all the titles and positions held by Prof. Helen Rees, who is leading the SA part of a global trial to identify treatments for COVID-19, there would be no space to write anything else.

    April 9, 2020
  • The image on the slide deck was stark — a chart in the form of a towering blue mountain that showed the US facing a potential 2.2m deaths from coronavirus, were certain measures not taken. But the voice delivering the message was calm, almost soothing.

    April 6, 2020
    Financial Times
  • In biomedical research, there is a “before HIV” era, and the world we live in now. Before HIV, most responses to public health crises were dictated top-down by government authorities and medical officials. Research was designed and conducted with little or no community input. Innovation was shunned, collaboration between research institutions avoided, and progress was slow.

    April 6, 2020
    Science Speaks
  • Professor Gita Ramjee, a highly acclaimed scientist who dedicated her life to fighting and preventing HIV, has sadly died of coronavirus.

    April 2, 2020
    Pink News
  • When the urgent phone call came last month, respected HIV researcher Deborah Birx was meeting with African officials and activists from around the world at a Johannesburg conference to help determine how US AIDS relief funding would be doled out.

    March 25, 2020
    Los Angeles Times
  • There was good news and bad news in terms of HIV vaccine and therapeutics research, with several vaccine trials pushing forward even as one came to a premature halt.

    March 13, 2020
    Antibody Related Research, HIV Vaccine
    MedPage Today